HIV Positive
30
1
1
25
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
1 terminated out of 30 trials
96.2%
+9.6% vs benchmark
13%
4 trials in Phase 3/4
28%
7 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 25 completed trials
Clinical Trials (30)
India HIV-CervCa Project
Thinking and Memory Problems in People With HIV
Pregnant and Parenting Teens Living With HIV in Lusaka, Zambia
The Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Implementation and Effectiveness of a Psychosocial Intervention Among Registered People Living With HIV(HIV Patients) at Pakistan Institute of Medical Sciences (PIMS) Islamabad Pakistan.
Integrated Treatment and Prevention for People Who Inject Drugs
Oligonucleotide Ligation Assay (OLA) Resistance Study
Alcohol Research Consortium in HIV-Intervention Research Arm
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects
CCTG 594: Engagement and Retention in Care for HIV+
IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
CCTG 593: Testing and Linkage to Care
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate
Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Transplantation and the Use of Raltegravir in HIV-Infected Patients
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy